skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

Journal Article · · PLoS Pathogens
ORCiD logo [1];  [2]; ORCiD logo [3]; ORCiD logo [1]; ORCiD logo [4]; ORCiD logo [4];  [5]; ORCiD logo [6];  [5]; ORCiD logo [5]; ORCiD logo [3]; ORCiD logo [7];  [1];  [1]; ORCiD logo [1];  [5];  [5];  [5];  [1];  [1] more »; ORCiD logo [5]; ORCiD logo [8];  [9];  [4];  [4];  [10];  [5]; ORCiD logo [10] « less
  1. Duke Univ., Durham, NC (United States). Medical Center. Dept. of Surgery
  2. Duke Univ., Durham, NC (United States). Medical Center. Duke Human Vaccine Inst.
  3. Dept. of Health and Human Services, Research Triangle Park, NC (United States). National Institutes of Health. National Institute of Environmental Health Sciences. Genome Integrity and Structural Biology Lab.
  4. National Inst. of Health (NIH), Bethesda, MD (United States). National Institute of Allergy and Infectious Diseases. Vaccine Research Center
  5. Duke Univ., Durham, NC (United States). Medical Center. Duke Human Vaccine Inst.; Duke Univ., Durham, NC (United States). Medical Center. Dept. of Medicine
  6. Duke Univ., Durham, NC (United States). Medical Center. Dept. of Surgery; Rory Henderson Duke Univ., Durham, NC (United States). Medical Center. Duke Human Vaccine Inst.
  7. Univ. of Oxford (United Kingdom). The Sir William Dunn School of Pathology
  8. Boston Univ., MA (United States). School of Medicine. Dept. of Microbiology
  9. Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Biology and Biophysics
  10. Duke Univ., Durham, NC (United States). Medical Center. Dept. of Surgery; Rory Henderson Duke Univ., Durham, NC (United States). Medical Center. Duke Human Vaccine Inst.

The CD4 binding site (CD4bs) of the HIV-1 envelope glycoprotein is susceptible to multiple lineages of broadly neutralizing antibodies (bnAbs) that are attractive to elicit with vaccines. The CH235 lineage (VH1-46) of CD4bs bnAbs is particularly attractive because the most mature members neutralize 90% of circulating strains, do not possess long HCDR3 regions, and do not contain insertions and deletions that may be difficult to induce. We used virus neutralization to measure the interaction of CH235 unmutated common ancestor (CH235 UCA) with functional Env trimers on infectious virions to guide immunogen design for this bnAb lineage. Two Env mutations were identified, one in loop D (N279K) and another in V5 (G458Y), that acted synergistically to render autologous CH505 transmitted/founder virus susceptible to neutralization by CH235 UCA. Man5-enriched N-glycans provided additional synergy for neutralization. CH235 UCA bound with nanomolar affinity to corresponding soluble native-like Env trimers as candidate immunogens. A cryo-EM structure of CH235 UCA bound to Man5-enriched CH505. N279K.G458Y.SOSIP.664 revealed interactions of the antibody light chain complementarity determining region 3 (CDR L3) with the engineered Env loops D and V5. These results demonstrate that virus neutralization can directly inform vaccine design and suggest a germline targeting and reverse engineering strategy to initiate and mature the CH235 bnAb lineage.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1627919
Journal Information:
PLoS Pathogens, Vol. 15, Issue 9; ISSN 1553-7374
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English

References (92)

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens journal June 1998
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line journal October 2002
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning journal August 2013
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody journal September 2012
Recent progress in broadly neutralizing antibodies to HIV journal October 2018
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies journal November 2018
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies journal May 2013
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers journal May 2014
Neutralization tiers of HIV-1 journal January 2018
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma journal January 2017
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice journal February 2016
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers journal May 2014
The quest for an antibody-based HIV vaccine journal January 2017
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 journal June 2018
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer journal February 2017
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody journal November 1994
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors journal March 2013
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex journal November 2014
New tools for automated high-resolution cryo-EM structure determination in RELION-3 journal November 2018
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design journal December 2015
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 journal July 2010
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates journal February 2017
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation journal May 2018
HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies journal January 2015
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus journal April 2013
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo journal August 2017
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody journal April 2016
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models journal December 2017
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies journal March 2016
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies journal May 2018
Host controls of HIV broadly neutralizing antibody development journal January 2017
Gctf: Real-time CTF determination and correction journal January 2016
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1IIIB gp120 journal December 2001
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta journal September 2016
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization journal August 2017
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains journal December 2017
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice journal October 2012
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth journal November 2016
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions journal October 2014
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies journal July 2014
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein journal March 2016
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades journal September 2002
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function journal June 2010
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes journal December 2015
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
Host Controls of HIV Neutralizing Antibodies journal May 2014
Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers journal December 2015
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein journal March 2017
Features and development of Coot journal March 2010
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals journal January 2010
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies journal March 2013
EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy journal August 2015
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure journal May 2018
Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1 journal June 2006
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 journal June 2011
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies journal June 2005
Antibodies in HIV-1 Vaccine Development and Therapy journal September 2013
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches journal June 2017
Antibody neutralization and escape by HIV-1 journal March 2003
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody journal May 2016
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies journal October 2012
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation journal April 2017
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors journal June 2015
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies journal September 2012
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing journal August 2011
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies journal August 2013
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope journal March 2004
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1 journal February 2009
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination journal February 2017
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites journal December 2002
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen journal August 2020
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome journal December 2019
Insights on autophagosome–lysosome tethering from structural and biochemical characterization of human autophagy factor EPG5 journal March 2021
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus text January 2013
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors text January 2015
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies text January 2014
Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses journal July 2022
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design journal August 2019
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98% journal November 2016
Mechanism of AAA+ ATPase-mediated RuvAB–Holliday junction branch migration journal August 2022
Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneity journal January 2018
Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion journal November 2012
Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals journal July 2011
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design journal February 2012
Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. journal January 1995
Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1 journal November 1998

Cited By (2)

Targeted selection of HIV-specific antibody mutations by engineering B cell maturation journal December 2019
Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements journal January 2020